UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 62 filers reported holding UROGEN PHARMA LTD in Q3 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $437 | +12.1% | 26 | 0.0% | 0.00% | – |
| Q1 2024 | $390 | -53.6% | 26 | -53.6% | 0.00% | – |
| Q4 2023 | $840 | +7.0% | 56 | 0.0% | 0.00% | – |
| Q3 2023 | $785 | +35.3% | 56 | 0.0% | 0.00% | – |
| Q2 2023 | $580 | +12.0% | 56 | 0.0% | 0.00% | – |
| Q1 2023 | $518 | -39.8% | 56 | -42.3% | 0.00% | – |
| Q4 2022 | $860 | -14.0% | 97 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 97 | -51.7% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 201 | -43.4% | 0.00% | – |
| Q1 2022 | $3,000 | -83.3% | 355 | -66.7% | 0.00% | -100.0% |
| Q3 2021 | $18,000 | +1700.0% | 1,065 | +2266.7% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 45 | -26.2% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 61 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 61 | +306.7% | 0.00% | – |
| Q3 2020 | $0 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,155,862 | $38,571,000 | 11.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 849,478 | $28,347,000 | 4.49% |
| Horton Capital Management, LLC | 108,670 | $3,626,000 | 3.53% |
| Prosight Management, LP | 217,686 | $7,264,000 | 3.19% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $98,598,000 | 2.35% |
| Phoenix Holdings Ltd. | 834,739 | $27,663,000 | 1.16% |
| SHIKIAR ASSET MANAGEMENT INC | 67,025 | $2,237,000 | 0.74% |
| MEITAV INVESTMENT HOUSE LTD | 272,063 | $9,080,000 | 0.66% |
| Clal Insurance Enterprises Holdings Ltd | 17,666 | $529,388,000 | 0.57% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $24,637,000 | 0.48% |